Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A CMV vaccine: TREATing despite the TRICKs.

Literature DB >> 24093909

A CMV vaccine: TREATing despite the TRICKs.

Chris A Benedict¹.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：
Cytomegalovirus Vaccines

Year: 2013 PMID： 24093909 PMCID： PMC3904538 DOI： 10.1586/14760584.2013.844653

Source DB: PubMed Journal: Expert Rev Vaccines ISSN： 1476-0584 Impact factor: 5.217

× No keyword cloud information.

19 in total

1. Functional map of human cytomegalovirus AD169 defined by global mutational analysis.

Authors: Dong Yu; Maria C Silva; Thomas Shenk
Journal: Proc Natl Acad Sci U S A Date: 2003-09-30 Impact factor: 11.205

Review 2. Development of a cytomegalovirus vaccine: lessons from recent clinical trials.

Authors: E Gonczol; S Plotkin
Journal: Expert Opin Biol Ther Date: 2001-05 Impact factor: 4.388

3. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.

Authors: S B Boppana; L B Rivera; K B Fowler; M Mach; W J Britt
Journal: N Engl J Med Date: 2001-05-03 Impact factor: 91.245

4. Maternal immunity and prevention of congenital cytomegalovirus infection.

Authors: Karen B Fowler; Sergio Stagno; Robert F Pass
Journal: JAMA Date: 2003-02-26 Impact factor: 56.272

Review 5. Natural killer cells: walking three paths down memory lane.

Authors: Gundula Min-Oo; Yosuke Kamimura; Deborah W Hendricks; Tsukasa Nabekura; Lewis L Lanier
Journal: Trends Immunol Date: 2013-03-14 Impact factor: 16.687

6. Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.

Authors: Scott G Hansen; Jonah B Sacha; Colette M Hughes; Julia C Ford; Benjamin J Burwitz; Isabel Scholz; Roxanne M Gilbride; Matthew S Lewis; Awbrey N Gilliam; Abigail B Ventura; Daniel Malouli; Guangwu Xu; Rebecca Richards; Nathan Whizin; Jason S Reed; Katherine B Hammond; Miranda Fischer; John M Turner; Alfred W Legasse; Michael K Axthelm; Paul T Edlefsen; Jay A Nelson; Jeffrey D Lifson; Klaus Früh; Louis J Picker
Journal: Science Date: 2013-05-24 Impact factor: 47.728

7. CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.

Authors: John R Šedý; Ryan L Bjordahl; Vasileios Bekiaris; Matthew G Macauley; Brian C Ware; Paula S Norris; Nell S Lurain; Chris A Benedict; Carl F Ware
Journal: J Immunol Date: 2013-06-12 Impact factor: 5.422

8. The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner.

Authors: Emma Poole; Anett Walther; Kathy Raven; Christopher A Benedict; Gavin M Mason; John Sinclair
Journal: J Virol Date: 2013-01-30 Impact factor: 5.103

Review 9. Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.

Authors: Vijayendra Dasari; Corey Smith; Rajiv Khanna
Journal: Expert Rev Vaccines Date: 2013-06 Impact factor: 5.217

10. Structure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactions.

Authors: Ivana Nemčovičová; Chris A Benedict; Dirk M Zajonc
Journal: PLoS Pathog Date: 2013-03-21 Impact factor: 6.823

7 in total

Review 7. Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.

Authors: Ranim El Baba; Georges Herbein
Journal: Front Immunol Date: 2021-09-08 Impact factor: 7.561

7 in total

A CMV vaccine: TREATing despite the TRICKs.

1. Functional map of human cytomegalovirus AD169 defined by global mutational analysis.

Review 2. Development of a cytomegalovirus vaccine: lessons from recent clinical trials.

3. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.

4. Maternal immunity and prevention of congenital cytomegalovirus infection.

Review 5. Natural killer cells: walking three paths down memory lane.

6. Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.

7. CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.

8. The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner.

Review 9. Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.

10. Structure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactions.

1. Structure of human cytomegalovirus UL144, an HVEM orthologue, bound to the B and T cell lymphocyte attenuator.

2. Cytomegalovirus Evades TRAIL-Mediated Innate Lymphoid Cell 1 Defenses.

Review 3. The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.

4. Profiling Human Cytomegalovirus-Specific T Cell Responses Reveals Novel Immunogenic Open Reading Frames.

Review 5. Cytomegalovirus: Shape-Shifting the Immune System.

Review 6. Subversion of Immune Response by Human Cytomegalovirus.

Review 7. Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.